LONG-TERM ANABOLIC THERAPY IN THE ELDERLY
- 1 November 1977
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 6 (4) , 221-227
- https://doi.org/10.1093/ageing/6.4.221
Abstract
The anabolic agent stanozolol has been used to increase weight and activity in the elderly, but its long-term effects are largely unknown. A double-blind trial of stanozolol against placebo was continued for 12 months. Measurements of weight, fat, fat-free mass, behviour and activity were made at regular intervala, plus detailed biochemical and hermatological profiles. There were no differences between the two groups in respect of weight, fat, fat-free mass and activity levels. There were significant increase in hemoglobin at six and 12 months and packed cell volume at 12 months in the active group. No androgenic side-effects were encountered.Keywords
This publication has 0 references indexed in Scilit: